# Calculet

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/calculet

- Industry: Semiconductors
- Headquarters: Beijing, China
- Website: www.calculet.com.cn/
- Latest round: Series A (Jul 24, 2026)
- Investors on record: 18

## About

Founded in 2023 and based in Beijing, China, Yuanli (Beijing) Semiconductor Technology Co., Ltd., trading as Calculet, is a semiconductor company that provides AI chips. The company's core focus is on delivering flexible computing support for the deployment of SoC and system factor's edge-end multi-modal large models. With a team of experts in multi-modal AI processor design and Chiplet methodology, Calculet offers solutions that cater to the specific needs of various business scenarios. Mr. Shaoxia Fang, the founder and CEO of the company, used to be the research and development director of the AI processor of the international semiconductor giant. In July 2026, Calculet raised over CNY 700 million in series A funding from Andon Health, By-Health, LY ECO, Peiyang Begonia, Renai Capital, IDG Capital, Summitview Capital, Innoangel Fund, Yiwei (Hainan) Venture Capital and other investors.

The company's products and services revolve around the development of AI Chiplet components, aiming to enhance the performance and reduce the costs associated with edge computing. It uses multi-modal AI processor technology to design AI Chiplets, and configures AI chips with different computing power specifications, such as autonomous driving chips, intelligent robot chips, etc.

The company’s revenue is generated through the sale of AI chiplet hardware products and related technical services to enterprise customers, including customized chip configurations and development support for edge computing and AI inference deployments.

The company will use the latest funding to accelerate the development and commercialization of its Agent-oriented edge AI chips and computing platform.

## Funding rounds

- Series A, Jul 24, 2026 — IDG Capital, Summitview Capital, Innoangel Fund, By-Health, Renai Capital, Peiyang Begonia, Andon Health, Yiwei (Hainan) Venture Capital, LY ECO
- Series A, Dec 25, 2025 — Shangshi Fund, Midas Capital, Beijing Capital Science and Technology Development Group Investment Management, Innoangel Fund, Yuanshi Investment, Lynnovest
- Seed, Jun 27, 2023 — Zero2IPO Ventures, Casstar Capital, Shuimu Qinghua Capital, Innoangel Fund, Zhongguancun Development Venture

## Investors

- Zero2IPO Ventures (https://capitalatlas.ai/funds/zero2ipo-ventures) — Seed
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Seed
- Shuimu Qinghua Capital (https://capitalatlas.ai/funds/shuimu-qinghua-capital) — Seed
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Seed, Series A
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Seed
- Shangshi Fund (https://capitalatlas.ai/funds/shangshi-fund) — Series A
- Midas Capital — Series A
- Beijing Capital Science and Technology Development Group Investment Management (https://capitalatlas.ai/funds/beijing-capital-science-and-technology-development-group-inv) — Series A
- Yuanshi Investment (https://capitalatlas.ai/funds/yuanshi-investment) — Series A
- Lynnovest — Series A
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Summitview Capital (https://capitalatlas.ai/funds/summitview-capital) — Series A
- By-Health — Series A
- Renai Capital (https://capitalatlas.ai/funds/renai-capital) — Series A
- Peiyang Begonia — Series A
- Andon Health — Series A
- Yiwei (Hainan) Venture Capital — Series A
- LY ECO — Series A